NUAK2 and renal cell carcinoma: The K82 arginine (R) mutant is an inactive NUAK2 mutant, due to its interference with the NUAK2 autophosphorylation site inhibiting its anti-apoptotic activity in the ACHN renal cell carcinoma cell line [27].